APBB3 Polyclonal antibody

APBB3 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 12051-1-AP

Print datasheet

Synonyms

APBB3, FE65L2, Protein Fe65 like 2, SRA



经过测试的应用

Positive WB detected inhuman plasma

推荐稀释比

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 1 publications below

产品信息

12051-1-AP targets APBB3 in WB, ELISA applications and shows reactivity with human samples.

Tested Applications WB, ELISA Application Description
Cited ApplicationsWB
Tested Reactivity human
Cited Reactivitymouse
Immunogen APBB3 fusion protein Ag2681 种属同源性预测
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Full Name amyloid beta (A4) precursor protein-binding, family B, member 3
Synonyms APBB3, FE65L2, Protein Fe65 like 2, SRA
Calculated Molecular Weight 486 aa, 53 kDa
Observed Molecular Weight53 kDa
GenBank Accession NumberBC013158
Gene Symbol APBB3
Gene ID (NCBI) 10307
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDO95704
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

APBB3 is a member of the APBB protein family. It is found in the cytoplasm and binds to the intracellular domain of the Alzheimer's disease beta-amyloid precursor protein (APP) as well as to other APP-like proteins. It is thought that the protein encoded by this gene may modulate the internalization of APP.

实验方案

Product Specific Protocols
WB protocol for APBB3 antibody 12051-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
mouseWB

J Nanobiotechnology

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

Authors - Xuan Sha